Evidence map›Paper›PMID 16511206›Full record

ArticleActa crystallographica. Section F, Structural biology and crystallization communications2005

Crystallization and preliminary crystallographic analysis of the human calcineurin homologous protein CHP2 bound to the cytoplasmic region of the Na+/H+ exchanger NHE1.

Youssef Ben Ammar, Soichi Takeda, Mitsuaki Sugawara, Masashi Miyano, Hidezo Mori, Shigeo Wakabayashi

Open access · bronzeAbstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology and crystallization communications, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Involvement of CHP2 in the Development of Non-Small Cell Lung Cancer and Patients' Poor Prognosis.Applied immunohistochemistry & molecular morphology : AIMM · 2020
    Article
  3. Review
  4. NHE3 regulatory complexes.The Journal of experimental biology · 2009
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Youssef Ben AmmarDepartment of Molecular Physiology, National Cardiovascular Center Research Institute, Fujishiro-dai 5-7-1, Suita, Osaka 565-8565, Japan.
Soichi Takeda
Mitsuaki Sugawara
Masashi Miyano
Hidezo Mori
Shigeo Wakabayashi
National Cerebral and Cardiovascular Center · JPSPring-8 · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcineurin homologous protein (CHP) is a Ca2+-binding protein that directly interacts with and regulates the activity of all plasma-membrane Na+/H+-exchanger (NHE) family members. In contrast to the ubiquitous isoform CHP1, CHP2 is highly expressed in cancer cells. To understand the regulatory mechanism of NHE1 by CHP2, the complex CHP2-NHE1 (amino acids 503-545) has been crystallized by the sitting-drop vapour-diffusion method using PEG 3350 as precipitant. The crystals diffract to 2.7 A and belong to a tetragonal space group, with unit-cell parameters a = b = 49.96, c = 103.20 A.

Indexed as

CalcineurinCalcium-Binding ProteinsCation Transport ProteinsCell MembraneCrystallizationCrystallography, X-RayCytoplasmDiffusionElectrophoresis, Polyacrylamide GelEscherichia coliHumansMembrane ProteinsPolyethylene GlycolsProtein IsoformsProtein Structure, TertiarySodium-Hydrogen Exchanger 1CalcineurinCalcium-Binding ProteinsCation Transport ProteinsCHP1 protein, humanMembrane ProteinsPolyethylene GlycolsProtein IsoformsSLC9A1 protein, humanSodium-Hydrogen Exchanger 1Sodium-Hydrogen Exchangers

Identifiers

PMID16511206
PMCPMC1991313
OpenAlexW2020813308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.